Strengths of this study focused on that we found that CAD GWAS risk variants at the CSTF2T locus were closely associated with increased CSTF2T expression in whole blood tissue, suggesting that CSTF2T may promote atherosclerosis, which may be a future direction for the treatment of atherosclerosis. This evidence concerns the gene CSTF2T and coronary artery disorder.